This content is machine translated The somewhat different knowledge Cancer therapy and fingerprinting: a search for traces of lost papillary lines. Fingerprinting before entering a foreign country? Quickly unlock your smartphone using fingerprint technology? What seemed self-evident yesterday can become impossible for cancer patients within a very short time. Although the…
View Post 4 min This content is machine translated Atopic dermatitis: biologics Dupilumab also effective and safe in under 12-year-olds In Switzerland, the approval of the highly effective biologic Dupilumab in the indication area of atopic dermatitis has so far been limited to adult and adolescent patients aged 12 years…
View Post 6 min This content is machine translated Type 2 diabetes: SURE Switzerland study New “real world” data on semaglutide in subcutaneous form convincing The prospective, multicenter observational study SURE Switzerland investigated the efficacy of once-weekly subcutaneously administered semaglutide in patients with type 2 diabetes in clinical practice. Among other things, it was shown…
View Post 3 min This content is machine translated Atopic dermatitis: JAK inhibitors Baricitinib combined with topical steroids achieves high patient benefit When topical steroid therapy alone is not sufficiently effective, patients with atopic dermatitis may benefit greatly from the additional use of the JAK inhibitor baricitinib. This is shown, among other…
View Post 6 min This content is machine translated Stenosing and occlusive vascular diseases Recognizing and treating pAVK – important facts for family physicians In the worst case, peripheral arterial disease (pAVD) can lead to vascular occlusion and necessitate amputations; the risk of heart attack or stroke is also significantly increased in those affected.…
View Post 5 min This content is machine translated Psoriatic arthritis (PsA) Focus on the risk profile Approximately one-third of patients with psoriasis develop psoriatic arthritis (PsA). The events responsible for progression to PsA are still unclear. However, genetic and clinical demographic risk factors, particularly family aggregation…
View Post 5 min This content is machine translated BRAFV600 stage IV melanoma Targeted therapy: “real world” data on encorafenib plus binimetinib The BERING-Melanoma multicenter study is monitoring the use of encorafenib with binimetinib in the first- and second-line setting* in patients with advanced BRAFV600-mutated malignant melanoma in everyday care in Germany, Austria,…
View Post 12 min This content is machine translated Axial spondyloarthritis and psoriatic arthritis Effective and efficient against pain The anti-IL-17A monoclonal antibody ixekizumab has already been approved since 2016 for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. In 2020, axial spondyloarthritis (axSpA) was added… CME-Test
View Post 7 min This content is machine translated Psoriasis in childhood and adolescence Secukinumab in juvenile plaque psoriasis – sustained efficacy demonstrated Treatment options for psoriasis patients in childhood and adolescence are much more limited compared to the treatment spectrum for adults. But pediatric patients can also benefit from targeted treatment. This…
View Post 6 min This content is machine translated Multiple Myeloma CAR-T cells, autologous and allogeneic stem cell transplantation: Who is winning the race? Autologous stem cell transplantation is highly valued in the treatment of multiple myeloma. In recent decades, the use of allogeneic blood stem cell transplantation has also been tested, but despite…
View Post 4 min This content is machine translated Rheumatoid arthritis Translational medicine and omics analyses: focus on proven and new therapeutic approaches In rheumatoid arthritis, the immune system attacks the synovial membrane of the synovium. If left untreated, there is a risk of gradual joint destruction. DMARDs are therefore used in severe…
